Blood tests can pick up problems in the liver well before any symptoms develop. The commonest cause of abnormal liver tests is fatty liver...

Article

Extended funding for adalimumab (Humira)

Adalimumab is now available for Crohn's disease with fistula formation. This is a severe and disabling complication of Crohn's disease. Often patients with this problem could be funded based on other criteria. However having a complicated or significant fistula is now enough to justify funding for adalimumab. Treatment will need to be for several years as fistulas can be slow to respond

designed and developed by QT Web